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Abstract: The predominant indications for revision surgery after total hip (THA) or knee 
arthroplasty (TKA) are an aseptic failure (AF) and prosthetic joint infection (PJI). Accurate 
diagnosis is crucial. Therefore, we evaluated prospectively a multidisciplinary diagnostic 
algorithm including multi-modal radionucleid imaging (RNI) and extended microbiological 
diagnostics. If the surgeon suspected PJI or AF, revision surgery was performed with multiple 
samples obtained in parallel for special culture procedures and later molecular analyses. 
Alternatively, if the underlying cause was not evident, RNI was scheduled comprising 99Tc – HDP 
SPECT/CT, 111In-labeled white blood cells combined with 99Tc-nanocoll bone marrow SPECT/CT, 
and 18F-FDG PET/CT. A multidisciplinary clinical team made a recommendation on the indication 
for a diagnostic procedure guided by RNI images or revision surgery. A total of 156 patients with 
163 arthroplasties were included. Fifty-five patients underwent RNI. In all, 118 revision surgeries 
were performed in 112 patients: 71 on the indication of AF and 41 revision of PJI. Thirty-four 
patients were concluded with chronic pain, and revision surgery refrained. The effective median 
follow-up period was 13 months. A structured approach offered by the algorithm was useful for 
the clinician in the evaluation of patients with a failing TKA or THA. Surgical revision was possibly 
obviated in approximately 20% of patients where an explanation or cause of failure was not found. 
The algorithm served as an effective tool. 
Keywords: prosthesis; infection; algorithm; diagnosis 
 
1. Introduction 
Complications after total hip (THA) or knee arthroplasties (TKA) present an increasing 
challenge for the health services, primarily reflecting a rising number of primary surgeries [1]. In 
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general, complications can be divided into a prosthetic joint infection (PJI), aseptic failure (AF) (most 
of which are implant loosening, instability, and polyethylene wear) [2], and an exclusion diagnosis 
of chronic pain. In Scandinavian countries, the leading indication for revision surgery is AF, 
followed by PJI [3–5]. The risk of a PJI is reported to be one to two percent and is associated with 
appreciable morbidity, and are complex to diagnose and treat [6–8]. Previous studies have projected 
a threefold rise in the number of revision surgeries due to PJI by the year 2030 [9]. 
Appropriate diagnosis is paramount for successful treatment. Pain, not being a discriminating 
symptom, is the most frequent clinical manifestation in PJI and AF [10]. Pre- and intraoperative 
diagnosis of acute infection is often straightforward, but overt local or systemic findings can be 
lacking, hence being dependent on a microbiological diagnosis. Cases with culture-negative 
infections pose a special challenge [11], and a causative role of low-grade infection in AF has been 
indicated in a number of studies [12–15]. Finally, non-confirmation of a preoperative diagnosis of 
chronic infection by culture may leave a notion that the procedure was superfluous. 
Efforts have been made to reach a consensus regarding diagnosing a prosthetic problem [16]. 
However, an international consensus has not been achieved, and surgeons must decide individually 
which diagnostic tools to employ [17]. Detailed patient history and meticulous clinical examination 
is fundamental and can be supplemented in a number of ways [18]. 
Culture methods have been the main diagnostic tool for PJI [11,18,19]. An intraoperative 
sampling of multiple biopsies became a standard in the 1990s, and more recently, laboratory 
processing of prosthetic components has become an adjunct to detect biofilm infections. Gene 
amplification methods have been introduced in various forms and evaluated in a number of studies 
[20,21]. 
A prospective study has not yet been performed with a diagnostic algorithm incorporating RNI, 
optimized sampling logistics, culturing methods, and 16S rRNA gene polymerase chain reaction 
(PCR), and amplicon sequencing. Our hypothesis is that a structured multidisciplinary algorithm is 
applicable in a clinical setting and can improve diagnosis in patients experiencing a post-hip or knee 
replacement problem. 
2. Materials and Methods 
This study was conducted in North Denmark Region from December 2011 to January 2014 
within the framework of an innovation consortium with participation of clinical departments, 
universities, industry, and the Danish Technology Institute (Danish acronym PRIS). Department of 
Orthopedic Surgery, Aalborg University Hospital was responsible for inclusion, treatment, and 
coordination. A multidisciplinary algorithm aimed to improve the diagnosis of patients presenting 
with a prosthetic problem related to either a TKA or THA (Figure 1). The main difference from the 
standard course for such patients was the option for RNI and extended set of samples obtained 
during revision surgery. 
2.1. Inclusion 
Patients with TKA or THA were referred by either general practitioners or other clinical 
departments. Inclusion criteria were a prosthetic failure and suspected infection. Failure was defined 
as pain and a mechanical problem (loosening or wear evident by X-ray imaging and physical 
examination). Exclusion criteria were recurrent dislocation of the hip arthroplasty or age below 18 
years. 
Clinical evaluation was performed by a specialized team of orthopedic surgeons. Standard 
biochemical tests and X-ray imaging were requested if necessary but was not an inclusion criterion. 
The overall clinical assessment at inclusion was the outset for the algorithm. Surgery for acute 
infection was scheduled if PJI was suspected clinically within eight weeks from the index procedure, 
or a hematogenous infection was suspected in a septic patient. If PJI was suspected after 8 weeks 
since the index procedure, an evaluation for a chronic problem was scheduled. If there was no 
clinical suspicion of PJI, patients were quarantined for eight weeks after which they were concluded 
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if symptoms remitted. If not, evaluation for a chronic problem continued. Revision for AF was 
scheduled if radiographic or clinical signs of failure were present, and PJI was not suspected. 
2.2. Evaluation of a Chronic Problem 
A chronic problem was suspected if none of the criteria above were satisfied. RNI was 
performed on three consecutive days, including 99Tc – HDP SPECT/CT, 111In-labeled white blood cell 
(WBC) combined with 99Tc-nanocol bone marrow SPECT/CT, and 18F-FDG PET/CT, see Appendix A 
for RNI-protocol. In a multidisciplinary conference, specialists in nuclear imaging, orthopedic 
surgery, and clinical microbiology evaluated the findings. If findings were compatible with 
infection, a diagnostic procedure or revision surgery was recommended. In the absence of findings 
suggestive of PJI, patients were diagnosed as having a chronic pain problem, and follow-up for 
change in status was planned. 
2.3. Revision Surgery 
Sampling during revision surgery was identical regardless of indication. Before the 
administration of antibiotics, five periprosthetic synovial tissue biopsies were obtained, according to 
Kamme & Lindberg [22], as is the routine in the Department of Orthopedic Surgery. Intraoperative 
project samples followed a previously published protocol [23]. Project samples included triplicates 
of joint fluid, periprosthetic synovial tissue and bone biopsies, and swabs from the surface of the 
prosthesis. This sampling strategy made it possible to evaluate experimental methods. Any removed 
prosthetic components were handled aseptically and subjected to sonication according to a 
previously published protocol [24]. For more details, see Appendix B. Protocol samples were subject 
to bacteriological culturing for 14 days, 16S rRNA gene PCR followed by amplicon sequencing, and 
fluorescence in situ hybridization (FISH) (optional). Surgical treatment was not the scope of this 
study and was left to the surgeon’s discretion. 
2.4. Clinical Follow-Up 
Clinical follow-up was by appointment with the surgeon within six months. A unique civil 
registration number is used for medical records and laboratory information systems. In August 2015, 
the first author made a review of later contacts with the Department of Orthopedics and any 
microbiological samples of relevance (wwLab, Autonik, Sweden). 
2.5. Data Sources 
Baseline characteristics of patients, comorbidities, previous history of the affected joint, and 
prior antibiotic treatment were obtained from medical records, and blood biochemistry values were 
from the laboratory information system (Labka, CSC, Denmark) (C-reactive protein (CRP) normal 
range ≤8 mg/L; WBC count normal range 3.5–10.0 × 109/L). 
2.6. Diagnosis 
Following the algorithm, patients obtained either a diagnosis of acute infection, chronic 
infection, AF, or chronic pain. Acute infection was a clinical diagnosis, and joint aspiration was 
recommended. Diagnosis of AF and chronic infection were supported by clinical findings and RNI, 
joint aspiration, and bioptic procedures being optional. Chronic pain was a diagnosis reached by the 
exclusion of the aforementioned diagnoses (i.e., clinical suspicion not supporting AF or PJI and 
absence of ‘hot-spots’ by RNI and a bioptic procedure with a negative culture). 
In patients undergoing revision surgery, confirmation of PJI required positive culture reports 
for at least three of five periprosthetic soft tissue biopsies with an identical microorganism(s). This 
criterion had been used by the Department of Orthopedic Surgery since the 1990s, and a validation 
study has previously been performed for patients with knee arthroplasty [22,25]. Less stringent 
criteria have been proposed by others [26], and therefore, an additional analysis was performed for 
patients with two positive tissue biopsy cultures with identical microorganism(s). A diagnosis of 
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culture-negative PJI was made if the clinical findings, including intra-operative view, was 
suggestive of PJI without fulfilling other criteria for PJI. Definitions of postoperative and post RNI 
diagnoses are shown in Figure 2. 
16S RNA gene PCR and amplicon sequencing was performed after closing the study, and thus, 
the results were not available to the surgeon. 
2.7. Case Definition and Data Analysis 
A case was defined by a specific arthroplasty and a 6-month follow-up period from study entry. 
After that period inclusion of the same arthroplasty was permissible as a new case. This arbitrary 
time limit was chosen for defining a new primary infection. Revision prompted by possible 
recurrence within six months and a debut of symptoms from another arthroplasty were likewise 
included as separate cases regardless of the timespan from the previous inclusion. 
For the primary analysis, cases were divided into four groups according to the algorithm: acute 
infection, chronic infection, AF, and chronic pain. Next, PJI and AF cases were stratified based on 
culture reports from revision surgery: PJI or AF cases could be confirmed or rejected, and as a 
consequence being referred to as the other diagnostic group. Cases for whom the modified criterion 
for PJI was fulfilled (i.e., only two culture-positive periprosthetic tissue biopsies) were designated 
‘PJI indeterminate’. If the diagnosis of PJI was supported by intraoperative observations but not by 
conclusive positive cultures, the case was referred to as ‘PJI culture-negative’. 
Patients evaluated with RNI were assessed post hoc by a multidisciplinary team (MDT) blinded 
to patient identity and imaging results. These 55 patients were divided into three groups: PJI, no PJI, 
and indeterminable (see Appendix C for further description of the MDT-process). 
Comparisons were made by Fisher exact test, and binomial confidence limits were calculated 
(Stata 12, Stata Corp., Texas). 
Approval of the PRIS project was obtained from the Research Ethics Committee for the North 
Denmark Region (N-20110022) and the Danish Data Protection Agency (2008-58-0028). 
 
Figure 1. The algorithm. 
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Figure 2. Definition of postoperative and post-radionucleid diagnosis. 
3. Results 
A total of 156 patients (163 cases) were included (85 TKA and 71 THA). A total of 118 revision 
surgeries were performed in 112 patients. The patient flow is depicted in Figure 3. Descriptive 
characteristics of patients at baseline, during the study and follow-up, are shown in Table 1. Key pre- 
and postoperative findings from the study are shown in Table 2. 
We applied logistic regression models to patients with PJI (acute and chronic), AF or chronic 
pain to define the strength of the association with nine variables (sex, age, Body Mass Index (BMI), 
C-Reactive Protein (CRP), White Blood Cell (WBC), TKA or THA, prosthesis age in year and number 
of comorbidities) as the independent variables. 
Suspected and confirmed AF was negatively associated to elevated CRP (p = 0.001 and p = 
0.01)). 
Acute infection was associated with increased CRP (p = 0.002). Chronic infection was associated 
with male sex (p = 0.030), high BMI (p = 0.038) and number of comorbidities (p = 0.011). 
PJI and Indeterminable were associated with increased CRP (p = 0.004 and p = 0.042). Chronic 
pain as an outcome was associated with increased BMI (p = 0.019). 
The negative predictive value of CRP < 7.0 and no infection was 100% in cases of AF (91.0–100, 
95% CI) and 100% in cases of chronic pain (80.5–100, 95% CI). However, the sample size was small, 
with few events. 
3.1. Aseptic Failure 
71 patients (72 cases) underwent revision in the AF group. In two patients, a joint aspirate was 
culture-negative, and six patients underwent RNI not conclusive for PJI or AF. Five patients (7.0%) 
were diagnosed postoperatively as PJI and treated at the surgeon’s discretion; two patients remained 
‘PJI indeterminable’. During follow-up, one patient was readmitted beyond the study and treated 
for PJI. Findings from the second revision did not suggest a causal relation with the condition prior 
to the first revision. 
3.2. Acute Infection 
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Nineteen patients underwent 20 revisions (one patient had two revisions of the same joint 
within six months), and eight patients had prior joint aspiration. PJI was confirmed in 16 patients (17 
revisions); one patient remained ‘PJI indeterminable’ and two ‘PJI culture negative’. 
3.3. Chronic Problem 
A total of 55 patients were evaluated for a chronic problem, 19 patients of whom underwent 
revision surgery (13 for PJI and six for AF, respectively). AF was not suspected at inclusion in the six 
patients. RNI was not conclusive for AF or PJI, although clinical judgment supported revision 
surgery for AF in these six patients. 
One patient had been treated within the study seven months earlier for an acute infection of the 
same joint. Following RNI, revision for chronic infection was scheduled. Prior to imaging, four had a 
culture-negative joint aspiration within the study. A bioptic procedure was done in 11 patients 
guided by results from RNI (seven percutaneous biopsies and four joint aspirates). 
Two patients strongly suspected of PJI were lost from the study. One patient had a bioptic 
procedure with positive culture suggesting PJI and was not fit for surgery. Another patient had 
revision surgery beyond the study for PJI. 
Chronic pain was concluded in 34 patients. Three patients had a culture-negative bioptic 
procedure guided by RNI. One of these patients was included again 11 months later and underwent 
revision surgery for chronic infection. Another two patients underwent revision surgery for AF 
during follow-up; standard cultures were negative. Results from RNI will be published elsewhere. 
3.4. Chronic Infection 
Twenty-six revision surgeries (two patients with revision of the same joint within six months) 
were performed in 22 patients (24 cases; one patient was included nine months later with the same 
joint, and one with TKA and THA was included with both four months apart). Thirteen of these 
patients had undergone RNI, as described above. 
PJI was confirmed in 17 patients (20 revisions). ‘PJI indeterminable’ applied to three patients 
(four revisions). In one patient, PJI was not confirmed and thus diagnosed as AF. PJI-culture 
negative was concluded in one patient. 
Nine patients had a culture-negative joint aspiration and were concluded without revision 
surgery. Three patients were lost from the study after joint aspiration, one being treated for AF and 
two for PJI outside the study. 
Diagnostics 2020, 10, 98 7 of 14 
 
 
Figure 3. Flowchart. 
Table 1. Characteristics of 156 patients experiencing a post-hip or knee replacement problem. 
Characteristics Values 
Age, years (median, IQR) 68.4 (63.0–76.0) 
Sex, number (females) 80 
Joint prosthesis (n, %)  
Hip 71 (45.5%) 
Knee 85 (54.5%) 
Comorbidities (n, %)  
Rheumatic disease 18 (11.5%) 
Cardiovascular disease 30 (19.2%) 
Diabetes mellitus 23 (14.7%) 
Cancer 16 (10.3%) 
COPD 5 (3.2%) 
Biological immunotherapy 17 (10.9%) 
Prosthesis, age, years (median, IQR) 8.1 (1.6–14.4) 
Indication for previous surgery (n, %)  
Aseptic failure  23 (14.7%) 
Prosthetic joint infection 26 (16.7%) 
Prior antibiotic treatment (n, %)) 30 (19.2%) 
Algorithm (n, %)  
Initial joint puncture 31 (19.9%) 
Radionucleid imaging 55 (35.3%) 
Bioptic procedure in patients with radionucleid imaging 11 (20%) 
Assesment by multidisciplinary team (MDT) (n,%) 55 (35.3%) 
Loss to follow-up including death (n, %) 5 (%) 
Follow-up period, days (median, range) 398 (3–1244) 
Table 2. Key pre- and postoperative findings. 
Key findings     
Preliminary diagnosis. No. of patients (and revisions) 
Aseptic 
failure 
n = 71 (72) 
Acute 
infection 
n = 19 * (20) 
Chronic 
infection 
n = 22∆* (26) 
Chronic painn 
= 34 
Age, years (mean, SD) 70.0 (12.5) 72.5 (10.8) 63.5 (11.8) 66.0 (10.2 
Sex, number (females) 40 13 6 16 
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Joint     
Hip 35 7 11 14 
Knee 36 12 11 20 
Prosthesis, age, years (median, interquartile range (0.25–
0.75) 
9.3 (2.8–
15.7) 
7.0 (0.5–14.7) 10.0 (1.5–15.0) 9.3 (1.6–9.4) 
Blood biochemistry values and antibiotic treatment 
(within 4 weeks) at inclusion 
    
CRP (µg/mL, median and range) 8 (1–92) 164 (11–394) 47 (5–345) 6 (0–19) 
WBC (range 109/L, median and range) 7 (3–12) 10 (5–24) 7 (4–11) 14 (2–15) 
Prior antibiotic treatment (no.) 3 11 8 2 
Confirmed diagnosis based on work up of project samples 
from revision surgery 
    
Aseptic failure (confirmed) 64 (65) 0 1 - 
Prosthetic joint infection (confirmed) 5 16 (17) 17 (20) - 
PJI-culture negative 0 2 1 - 
PJI-indeterminable 2 1 3 (4) - 
Follow-up     
Follow-up period, days (median and range) 
391 (3–
1131) 
292 (15–
1065) 
498 (21–1031) 379 (14–1095) 
Indication for revision during follow-up (n)     
Aseptic failure 4 1 5 2 
Prosthetic joint infection 1 4 4 1∆ 
∆ One patient included twice. Firstly, diagnosed with chronic pain after radionucleid imaging. 
Secondly, with chronic infection in the study during follow-up. * One patient included twice. Firstly, 
revision for acute infection. Secondly for chronic infection (prior radionucleid imaging). 
4. Discussion 
In this study, we summarize major findings in 156 prospectively recruited patients representing 
163 cases who were assessed by the use of a multidisciplinary diagnostic algorithm. To our 
knowledge, this is the first study of its kind. The few exclusion criteria make the study 
representative for patients with a problem related to a THA or TKA. 
It is important to distinguish between PJI and AF, as the appropriate course of treatment is 
different. A definite diagnosis remains a challenge, especially when surgery is not planned. Patients 
undergoing revision surgery are at eight times higher risk of a subsequent PJI compared with 
patients undergoing a primary arthroplasty [24]. Therefore, alternative methods are warranted in 
order to strengthen indications for revision surgery. 
Joint aspiration was discouraged in the initial evaluation due to possible interference with RNI 
[27]. Following RNI, a recommendation was made for a diagnostic procedure or revision surgery. 
Invasive diagnostic procedures are a valuable option and should be employed when relevant. 
Despite using sterile techniques, concern exists for introducing infection in a sterile joint when 
employing invasive diagnostic procedures. Therefore, the decision-making process after evaluation 
of the chronic problem was left to the discretion of the surgeon and the patient. Hence, final 
diagnoses after RNI were made either by tissue culture (from a bioptic procedure or revision 
surgery) or a clinical follow-up, as reported by Aksoy et al. [25]. Details from RNI will be published 
elsewhere. 
Elevated CRP was associated with PJI and normal CRP with confirmed AF. These findings have 
been consistent with other studies [17,28]. 
Sensitization in the peripheral and central nervous system has been demonstrated in patients 
with chronic pain after TKA [29]. “Primum non nocere” is advised in these cases as the underlying 
cause may not require surgical treatment. Following the algorithm, we diagnosed 34 patients with 
chronic pain, one and two of whom were diagnosed during follow-up with PJI and AF, respectively. 
Consequently, 3/34 of patients diagnosed with chronic pain were misdiagnosed. The remaining 31 
patients did not undergo revision. The group had a clinical follow-up of 12 months (mean) and at the 
time of writing, none of these patients had a diagnosis of PJI recorded in national databases during 
27 months of follow-up (mean). We interpret this to support the study diagnosis. Patients presenting 
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with a failing THA or TKA, without clinical findings supporting the symptoms of pain pose a 
challenge. Special attention should be given to these patients before offering an invasive procedure. 
Diagnostic algorithms exist for evaluating failing arthroplasties in other joints, such as in 
shoulders and ankles [30,31]. Although similarities in indication for revision surgery (PJI and AF), 
this algorithm does not apply for evaluating other arthroplasties. It is noteworthy that principles for 
diagnosis are similar; however, differences also exist, e.g., distribution of microorganisms [30]. It 
would; however, be obvious to test this algorithm in other failing arthroplasties. 
Recently much attention has been given to alpha-defensin tested in synovial fluid in failing 
TKA and THA [19]. Alpha-defensin was not a part of the algorithm in this study. However, it would 
have an interesting and relevant supplement in the analysis of joint fluid for comparison to the 
protocol samples. 
Different sets of diagnostic criteria for PJI have been proposed by international societies and 
individual authors including the European Society of Clinical Microbiology and Infectious Diseases 
[32], the Musculoskeletal Infection Society [33], the Infectious Disease Society of America [34], and 
the group of Zimmerli et al. [35]. We chose in 2011 to maintain conservative criteria for PJI and 
allowing the project samples and extended laboratory workup being a foundation for revised 
criteria. Our post hoc analysis using conservative criteria confirmed the clinical diagnoses in 90 
patients (93 cases). Six patients changed diagnosis, and six additional patients fulfilled a modified 
criterion for PJI and are reported here as ‘PJI indeterminable’. We foresee that results obtained with 
16S rRNA gene PCR followed by amplicon sequencing may help to clarify this latter group. Data 
from culture and 16S rRNA in the different specimen types are published elsewhere [36]. 
The strength of this study was the prospective design, the added value from the 
multidisciplinary cooperation, and the implementation of a new diagnostic strategy offered through 
the algorithm. The validity of the study was increased by the diverse history of patients, and the 
recognition of patients’ and surgeons’ autonomy. Still, we did not foresee the complex trajectories of 
patients within the study (Figure 3). 
Limitations of the study are notable: RNI has not yet become standard techniques for TKA- and 
THA-related problems, and the interpretation had to be made cautiously. Therefore, it was 
unfortunate that bioptic procedures were not feasible for a sizable part of the patients. The 
evaluation of all patients undergoing RNI by an MDT was meant to compensate for this information 
bias, and it can be an effective tool in similar prospective studies. We did not measure applicability 
or improvement directly. The clinicians found that the algorithm qualified the clinical choice of 
treatment using the stepwise approach. RNI was not planned as a diagnostic tool for AF. 
Nevertheless, six patients were treated with revision surgery for AF after RNI. 
Patient flow in this study was highly individualized and reflected, in part, the complexity of 
this patient group. The a priori diagnosis may be changed through the clinical course based on 
laboratory results and clinical findings. 
The risk of PJI increases with the number of revisions, and we were reluctant to exclude patients 
at elevated risk. Still, the study would have benefitted from a less pragmatic case definition. 
In order to maintain consistency in diagnosis and treatment, we chose not to revise our routine 
diagnostic criteria for PJI with at least three positive cultures with the same pathogen. However, we 
foresee that the criterion of at least three concordant culture reports for sets of periprosthetic tissue 
biopsies can be decreased to two or more culture-positive biopsies (patients fulfilling a relaxed 
criterion only are here reported as ‘PJI indeterminable’). 
5. Conclusions 
Surgical revision was possibly obviated in approximately 20% of patients presenting with a 
chronic problem where an explanation or cause of failure was not found. However, clinical 
judgment remained as a key element in the algorithm. 
Accurate and efficient diagnostics are imperative for correct diagnosis and treatment. 
Assessment of a failed THA and TKA should follow a strict workup. Applying a multidisciplinary 
diagnostic algorithm in a clinical setting is feasible. It is our recommendation that a structured 
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approach with an algorithm serves as a useful tool in optimizing diagnostics and resulting in 
personalized patient treatment. The comprehensive investigation in our algorithm is not 
recommended in routine cases but may serve as an option in difficult cases. 
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Appendix A 
Protocols for radionuclide imaging procedures in PRIS-project 
The nuclear imaging procedures performed in the Department of Nuclear Imaging in Aalborg 
University Hospital within one week for every patient evaluated for chronic problems on three 
consecutive days, followed by a multidisciplinary team (MDT) meeting for further decision-making. 
All the imaging modalities were performed over the knee or hip region respectfully. 
Day 1 
Bone scan with 99Tc – HDP performed as static uptake followed by SPECT/CT with low dose CT 
on Siemens Hybrid scanner (Symbia T16, Siemens Medical Solutions, Erlangen, Germany) in 
accordance with institutional procedures. 
• The mean injected activity of 99Tc – HDP was 750 MBq. 
• The bone scan acquired approximately 2–3 h after tracer injection. 
• Uptake parameters: static uptake 10 min, matrix size 256c × 256, zoom factor 1.00. SPET/CT 
20 sec/view, 32 views, matrix size 128 × 128, zoom factor 1.00, iterative reconstruction. 
Day 2 
White blood cell (WBC) labeling procedure with 111In. Static uptake over the lungs 30 min after 
reinjection due to quality control of labeling. 
18F FDG PET/CT on GE Discovery VCT PET/CT scanner (GE Healthcare, Waukesha, WI, USA) 
in accordance with institutional procedures. 
• The mean injected activity of 18F FDG was 370 MBq. 
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• PET/CT was acquired approximately 60 min after tracer injection. 
Day 3 
111In-labeled WBC static and SPECT/CT uptake with low dose CT on Siemens Hybrid scanner 
(Symbia T16, Siemens Medical Solutions, Erlangen, Germany). 
Simultaneous 111In-labeled WBC scan combined with 99Tc-nanocoll bone marrow scan with 
SPECT/CT low dose CT, so-called DUAL scan performed on Siemens Hybrid scanner (Symbia T16, 
Siemens Medical Solutions, Erlangen, Germany). 
• The mean injected 111In-labeled WBC activity was 20 MBq. 
• The mean injected activity for 99Tc-nanocoll was 500 MBq. 
• Simultaneous Dual uptake performed 24 h after 111In-labeled WBC reinjection and 1 h after 
99Tc-nanocoll injection. 
• Uptake parameters: static uptake 15 min, matrix size 256 × 256, zoom factor 1.00. SPET/CT 45 
sec/view, 32 views, matrix size 128 × 128, zoom factor 1.00, iterative reconstruction. 
Appendix B 
Protocol for samples obtained during revision surgery: 
Project samples: PS 
Standard tissue samples: STS 
In order to minimize contamination, joint fluid was aspirated once the joint was exposed, but 
prior to incision of the capsule (PS). Once the capsule was incised, three swabs were taken from the 
surface of the implant, in THA from the femoral head and in TKA from the femoral component. 
Immediately afterward, three synovial biopsies were taken from the vicinity of the prosthesis (PS). 
Next in line were five synovial tissue biopsies (STS) taken from the same area as the three samples. If 
only the polyethylene insert was exchanged, three periprosthetic bone biopsies were taken with a 
trocar from the bone-joint interface (PS). If other components were removed, bone sampling was 
withheld and taken from the exposed bone surface. All removed components were collected and 
placed directly in an assigned container by the surgeon (PS). 
Sampling was done with sterile disposable utensils separate for each sample. Antibiotics were 
withheld until all samples were collected. Routine antibiotic treatment was intravenous cefuroxime 
until culture results were available (negative results were informed on day 6). 
Appendix C 
Decision-making based on radionucleid imaging was left to the discretion of the clinician based 
on the recommendation from the multidisciplinary conference. For patients who did not undergo a 
bioptic procedure or revision surgery, laboratory results for diagnostic samples were lacking. To fill 
this void, a multidisciplinary team (MDT) was appointed to assist in classifying these patients after 
the study had been closed. The team consisted of three consultants who were specialists in infectious 
disease, clinical microbiology, and orthopedic surgery, respectively. A comprehensive summary of 
all available medical records was prepared for each patient spanning the period from the primary 
arthroplasty to the study end. The main items in the data extract are shown in Table 1. 
The team was blinded from each other, and descriptions of nuclear imaging performed as part 
of the PRIS-project. Each member was asked to conclude: 
PJI 
PJI effectively ruled out 
If a conclusion was not possible, the members were presented with three scenarios. 
Scenario A; Nuclear imaging supports suspicion of PJI 
Scenario B: Nuclear imaging does not support the suspicion of PJI 
Scenario C: Nuclear imaging is inconclusive 
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For each scenario, members were asked to decide if the additional information was sufficient to 
conclude 1 or 2 (as above). Conclusions were collected, and agreement defined as two of three 
identical conclusions. 
Appendix C, Table A1. Main items in the data extraction. 
Baseline data  
Arthroplasty 
Indication for primary arthroplasty 
All other implants including other arthroplasties 
Revision surgery of any other implants including treatment and microbiological 
results 
Comorbidities 
 
Inflammatory disease, diabetes (type 1 and 2), cardiovascular disease, pulmonary 
disease, cancer, biological immunotherapy 
Biochemistry CRP, erythrocyte sedimentation rate (ESR), white blood cell count (WBC) 
Clinicians’ evaluation 
A complete extract was made from the Department of Orthopedic Surgery for the 
joint in question, including details from clinical examination (pain, local signs of 
infection) 
Imaging prior to PRIS-study, 
‘Prosthetic-Related Infection and 
Pain’ (Danish acronym) 
 
Extracts of all available descriptions including plain radiographs, ultrasound, 
magnetic resonance (MR) scan, X-ray computed tomography (CT), radionucleid 
imaging (beyond PRIS) 
Study period and follow-up  
Clinicians evaluation 
Extracts of records from the Department of Orthopedic Surgery, including clinical 
evaluation (pain, local signs of infection) and invasive procedures (joint aspiration, 
revision surgery, surgeon’s intraoperative view). Material regarding 
PRIS-radionucleid imaging was omitted 
Biochemistry  as above 
Imaging  as above 
Hospital contacts regarding 
infection (any) 
Records for all admissions or ambulatory contacts in North Denmark Region were 
reviewed. If an infection was noted (regardless of location), data was extracted 
Microbiology 
An extract for all received samples (regardless of anatomic site) was made from the 
database of the Department of Clinical Microbiology in the timespan from primary 
arthroplasty to study end 
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